M&T Bank Corp Has $435,000 Stock Position in Sarepta Therape

M&T Bank Corp increased its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 13.0% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,582 shares of the biotechnology company’s stock after acquiring an additional 411 shares during the quarter. […]

Related Keywords

Sarepta , Volgogradskaya Oblast , Russia , Richard Barry , Douglass Ingram , Jpmorgan Chase Co , First Horizon Advisors Inc , Citigroup , Sarepta Therapeutics Company Profile , Kb Financial Partners , Industrial Alliance Investment Management Inc , Alphacentric Advisors , Nasdaq , Mt Bank Corp , Securities Exchange Commission , Sarepta Therapeutics Inc , Cantor Fitzgerald , T Bank Corp , Barclays , Morgan Stanley , Sarepta Therapeutics , Free Report , Wealth Management , Horizon Advisors , Centric Advisors , Industrial Alliance Investment Management , Get Free Report , Exchange Commission , Director Richard Barry , Visit Holdingschannel , Sarepta Therapeutics Daily , Nasdaq Srpt , Srpt , Medical , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,